Autoimmune Hemolytic Anemia in a Patient with Chronic Myeloid Leukemia: Case Report
Published: 2022-04-14
Page: 21-24
Issue: 2022 - Volume 5 [Issue 1]
Benzineb Brahim *
Centre Hospitalo-Universitaire de Tlemcen, Algeria.
Belhadef Hanane
Centre Hospitalo-Universitaire de Tlemcen, Algeria.
Chekkaf Ismahane
Centre Hospitalo-Universitaire de Tlemcen, Algeria.
Mesli Naima
Centre Hospitalo-Universitaire de Tlemcen, Algeria.
*Author to whom correspondence should be addressed.
Abstract
Autoimmune hemolytic anemia is an unusual complication in chronic myeloid leukemia on Imatinib. In this case report, it had appeared in 76 year old male patient with major molecular response treated by Imatinib. During the etiological research, we had kept the drug or idiopathic causes. We had treated the patient as idiopathic autoimmune hemolytic anemia without Imatinib interruption and we had noted an improvement in anemia without losing the major molecular response.
Keywords: CML, AIHA, imatinib